By Cameron Chai
Research and Markets has declared the inclusion of a market report titled ‘Nanotechnology in Drug Delivery 2011-2021’ to its offering.
The application of the principles of life science to medical and biomedical study, the inefficiency of conventional drug delivery systems, enhanced global health and a drastic rise in the size of the worldwide aging population are the driving factors behind the growth of the market for nanotechnology-based drug delivery systems.
The comprehensive report offers insight into the capabilities of targeted nanotech drug delivery and its market prospective over the next 10 years. It covers an in-depth analysis of latest advancements in nanotech drug delivery and discusses market potential in the fiscal year 2021. It presents historical market growth for nanotech drug delivery for the period 2000-2010. It also offers outlook data for the nanotech drug delivery market for the period 2011-2021.
The geographic markets covered in the business report are the Americas, Europe, Asia and rest of the world. The report discusses in detail about the technologies associated with the current nanotech drug delivery market. It offers a technology adoption road map with forecast data for share of major nanotech drug delivery technologies and total addressable markets until 2021. It also covers various case studies of efficient and versatile nanocarrier applications.
According to Cientifica’s Chief Executive Officer, Tim Harper, companies focused on targeted drug delivery systems can realize several advantages such as patent extensions on available drugs that are optimized by nanotech drug delivery, especially in anti-cancer medicines. Some of the companies mentioned in the report include IOTA NanoSolutions, Lena Nanoceutics, Medical Nanotechnologies, Nano Interface Technology and GlaxoSmithKline.